The New Classification System for the Dystonias: Why Was It Needed and How Was It Developed?

Movement Disorders Clinical Practice

Volumn 1, Issue 4, 2014, Pages 280-284

  Jinnah, H A ^a   Albanese, Alberto ^b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

blepharospasm; spasmodic dysphonia; torticollis

Indexed keywords

BOTULINUM TOXIN;

BODY REGIONS; CLINICAL RESEARCH; COUNSELING; DEGENERATION; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DYSTONIC DISORDER; EDITORIAL; GENETIC DISORDER; HUMAN; KNOWLEDGE; NEUROPATHOLOGY; ONSET AGE; PARKINSONISM; PATHOGENESIS; PHENOMENOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS;

EID: 84929318901     PISSN: None     EISSN: 23301619     Source Type: Journal    
DOI: 10.1002/mdc3.12100     Document Type: Editorial

References (19)

1. Klein C, Fahn S. Translation of Oppenheim's 1911 paper on dystonia. Mov Disord 2013;28:851–862.
2. Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28:863–873.
3. Fahn S. The varied clinical expressions of dystonia. Neurol Clin 1984;2:541–554.
4. Marsden CD. Dystonia: the spectrum of the disease. In: Yahr MD, ed. The Basal Ganglia. New York, NY: Raven Press; 1976:351–367.
5. Thompson VB, Jinnah HA, Hess EJ. Convergent mechanisms in etiologically-diverse dystonias. Expert Opin Ther Targets 2011;15:1387–1403.
6. Jinnah HA, Hess EJ. Experimental therapeutics for dystonia. Neurotherapeutics 2008;5:198–209.
7. Fung VS, Jinnah HA, Bhatia K, Vidailhet M. Assessment of the patient with dystonia: an update on dystonia syndromes. Mov Disord 2013;28:889–898.
8. Bressman SB, Sabatti C, Raymond D, et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology 2000;54:1746–1752.
9. Xiromerisiou G, Houlden H, Scarmeas N, et al. THAP1 mutations and dystonia phenotypes: genotype phenotype correlations. Mov Disord 2012;27:1290–1294.
10. Defazio G, Berardelli A, Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain 2007;130:1183–1193.
11. Jinnah HA, Berardelli A, Comella C, et al. The focal dystonias: current views and challenges for future research. Mov Disord 2013;7:926–943.
12. Lohmann K, Klein C. Genetics of dystonia: what's known? what's new? what's next? Mov Disord 2013;28:899–905.
13. LeDoux MS. The genetics of dystonias. Adv Genet 2012;79:35–85.
14. LeDoux MS, Dauer WT, Warner T. Emerging molecular pathways for dystonia. Mov Disord 2013;15:968–981.
15. Neychev VK, Gross R, Lehericy S, Hess EJ, Jinnah HA. The functional neuroanatomy of dystonia. Neurobiol Dis 2011;42:185–201.
16. Lehericy S, Tijssen MA, Vidailhet M, Kaji R, Meunier S. The anatomical basis of dystonia: current view using neuroimaging. Mov Disord 2013;28:944–957.
17. Zoons E, Booij J, Nederveen AJ, Dijk JM, Tijssen MA. Structural, functional and molecular imaging of the brain in primary focal dystonia–a review. Neuroimage 2011;56:1011–1020.
18. Quartarone A, Hallett M. Emerging concepts in the physiological basis of dystonia. Mov Disord 2013;28:958–967.
19. Hallett M. Neurophysiology of dystonia: the role of inhibition. Neurobiol Dis 2011;42:177–184.